Trump promised cheaper drugs. Some prices dropped. Many others shot up.

SITREP: President Trump has initiated several measures to reduce pharmaceutical prices since the beginning of his second term. While some drug prices have decreased, many others have experienced significant increases. TACTICAL ASSESSMENT: This mixed outcome highlights the complexities of pharmaceutical pricing and the challenges in implementing effective reforms. The fluctuations in drug prices may impact public perception and trust in the administration's ability to manage healthcare costs. PROJECTED VECTORS: Future initiatives may be introduced to address the rising prices of certain medications, potentially leading to further regulatory changes.